
Technical analysis of Arrowhead Pharmaceuticals, Inc. (stock) with the Montbon Method — Elliott Waves, moving averages and a 0–100 score.
Arrowhead Pharmaceuticals, Inc. is a U.S. pharmaceutical company founded in 2003 and headquartered in Pasadena, California, that develops RNAi-based medicines for the treatment of various diseases. The company's pipeline includes several clinical-stage candidates, such as Plozasiran and Zodasiran in Phase 3 studies, along with numerous other therapeutic programs in earlier development stages. The company collaborates with major international pharmaceutical partners including GlaxoSmithKline, Takeda, Amgen, and Sarepta Therapeutics.
Description generated automatically from public sources; it may be inaccurate or out of date.
Score, Elliott Waves, moving averages and technical indicators — free, no card
If you're not registered we'll ask you to sign in (free), then open the ARWR analysis.
Montbon analyses markets with Elliott Waves, multi-timeframe moving averages and a 0–100 score summarising the technical setup. It is an informational screening tool.
Elliott Waves
Wave counting to frame the price structure.
MTF moving averages
Moving averages across timeframes to read the trend.
0–100 score
A technical summary of the setup, updated daily.
How is Arrowhead Pharmaceuticals, Inc. analysed technically?
Technical analysis of Arrowhead Pharmaceuticals, Inc. is based on price charts and indicators such as moving averages, RSI and MACD, to observe trend, momentum and volatility across different time horizons.
Which timeframes are used for Arrowhead Pharmaceuticals, Inc.?
The daily and weekly charts are typically used for medium-to-long-term trends, while intraday charts (for example 1-hour or 15-minute) are used for short-term movements.
What are Elliott Waves applied to Arrowhead Pharmaceuticals, Inc.?
Elliott Wave theory describes price moves as sequences of impulsive and corrective waves; applied to Arrowhead Pharmaceuticals, Inc. it helps frame the technical structure of the historical chart and is not a forecast.
Disclaimer. For informational purposes only; not financial advice or a recommendation. Montbon Analytics is not an authorised financial intermediary.
Are you an issuer and want a correction or removal? Write to info@montbon.com.